LEAD Therapeutics is a private biopharmaceutical company focused on drug discovery and early-stage development, with programs in preclinical development including a PARP inhibitor for oncology and a glycopeptide antibiotic for gram-positive infections
LEAD Therapeutics is a private biopharmaceutical company focused on drug discovery and early-stage development, with programs in preclinical development including a PARP inhibitor for oncology and a glycopeptide antibiotic for gram-positive infections.